HIBERCELL, INC.;THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
发明人:
BOSE, NANDITA,BEATTY, GREGORY
申请号：
CA3093820
公开号：
CA3093820A1
申请日:
2019.03.13
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The present invention relates to the combination of ß-glucan and a CD40 agonist for cancer immunotherapy. The combination therapy shows synergistic anti-tumor activity that is dependent on T cells. Surprisingly, the combination therapy is effective against poorly immunogenic tumors.
